Ventripoint Announces Director Resignation
"
Toronto, Ontario – July 22, 2024 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV: VPT; OTC: VPTDF) announces that Robert Hodgkinson has resigned as a director of the Company effective July 22, 2024.
“Robert has been an amazing Director for the last 5 years. His enthusiasm for the Company has known no bounds. Nevertheless, it is the hallmark of good governance to have board renewal and so the Company will be appointing a new Director in due course”; stated Dr. George Adams, Executive Chairman of the Ventripoint.
Mr. Hodgkinson will continue to advise the Company as he has joined the Board of Business Advisors, which is chaired by Samuel Schwartz.
The Company wishes to thank Robert Hodgkinson for his valuable contributions to the Company and wishes him success in his future endeavors."
Sedar.com